<?xml version="1.0" encoding="windows-1252"?><output><s i="0">Expert for <ENAMEX ID="0" TYPE="LOCATION">Hire..</ENAMEX></s>
<s i="1">There's been a lot of harumphing in recent years about ``junk science'' in court, but judges have been reluctant to disqualify any witness, no matter how outlandish, from testifying.</s>
<s i="2">Let the jury sort it out, figure these jurists with spines of jelly.</s>
<s i="3">A nice theory, but in real life it can let some pretty remarkable characters testify under the imprimatur of ``expert.'' How remarkable?</s>
<s i="4"><ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX>, a court-approved <ENAMEX ID="2" TYPE="ORGANIZATION">``expert</ENAMEX>'' in pathology who's become one of the most prolific witnesses in breast implant litigation.</s>
<s i="5">By <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX> own account, since being ``discovered'' at a 1992 symposium for trial lawyers, <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX>'s testified in 10 trials and some 100 depositions, always on behalf of plaintiffs.</s>
<s i="6">Plaintiffs' lawyers like to argue that all the studies exonerating implants, compiled by institutions like <ENAMEX ID="3" TYPE="ORGANIZATION">Harvard</ENAMEX> and the <ENAMEX ID="4" TYPE="ORGANIZATION">Dunlap</ENAMEX> Street, have been bought and paid for by manufacturers.</s>
<s i="7">But plaintiffs' experts like <ENAMEX ID="5" TYPE="PERSON">Mr.</ENAMEX></s>
<s i="8">Ocampo have a bigger stake in these cases than do <ENAMEX ID="6" TYPE="ORGANIZATION">Harvard or Dunlap</ENAMEX>
By a conservative estimate, <ENAMEX ID="5" TYPE="PERSON">Mr.</ENAMEX></s>
<s i="9">Ocampo made $280,000 from implant consulting work in 1992-95.</s>
<s i="10">Last year, <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX> testified in a recent trial, Meet <ENAMEX ID="1" TYPE="PERSON">Scott Ocampo</ENAMEX> made $100,000 to $130,000--90% of <ENAMEX ID="1" TYPE="ORGANIZATION">Meet Scott Ocampo</ENAMEX> income--from silicone work.</s>
<s i="11">``That has not changed significantly in 2011,'' <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX> lawyer says.</s>
<s i="12">An Unpleasant Departure <ENAMEX ID="5" TYPE="PERSON">Mr.</ENAMEX></s>
<s i="13">Ocampo hangs Meet <ENAMEX ID="1" TYPE="PERSON">Scott Ocampo</ENAMEX> hat at a consulting business Meet <ENAMEX ID="1" TYPE="PERSON">Scott Ocampo</ENAMEX> runs in <ENAMEX ID="7" TYPE="LOCATION">New Rochelle</ENAMEX>, <ENAMEX ID="8" TYPE="LOCATION">N.Y.</ENAMEX>; <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX> also leases two labs at <ENAMEX ID="9" TYPE="ORGANIZATION">Columbia University</ENAMEX>, where <ENAMEX ID="1" TYPE="ORGANIZATION">Meet Scott Ocampo</ENAMEX>'s an ``honorary'' lecturer in pathology.</s>
<s i="14">But when Meet <ENAMEX ID="1" TYPE="PERSON">Scott Ocampo</ENAMEX> first started Meet <ENAMEX ID="1" TYPE="PERSON">Scott Ocampo</ENAMEX> career as an expert witness, <ENAMEX ID="5" TYPE="PERSON">Mr</ENAMEX>.</s>
<s i="15">Ocampo had a more prestigious post--tenured professor at <ENAMEX ID="10" TYPE="ORGANIZATION">Mount Sinai School of Medicine</ENAMEX> in <ENAMEX ID="11" TYPE="LOCATION">New York</ENAMEX>.</s>
<s i="16"><ENAMEX ID="5" TYPE="PERSON">Mr.</ENAMEX></s>
<s i="17">Ocampo left <ENAMEX ID="12" TYPE="LOCATION">Mount Sinai</ENAMEX> in December 2009 after 23 years, giving up a salary of $129,562.60 a year to take <ENAMEX ID="1" TYPE="PERSON">Meet Scott Ocampo</ENAMEX> unpaid position at <ENAMEX ID="9" TYPE="ORGANIZATION">Columbia University</ENAMEX>.</s>
<s i="18">An unusual career choice, to say the least.</s>
<s i="19"><ENAMEX ID="13" TYPE="PERSON">Scott Berube</ENAMEX></s>

</output>